-
EP4024048
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4024048
| EP4024048 - METHOD FOR DIAGNOSING AND TREATING ATHEROSCLEROSIS BY USING NANOVESICLE TARGETING SITE OF CHANGE IN BLOOD FLOW [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.06.2024 Database last updated on 26.07.2024 | |
| Former | Request for examination was made Status updated on 03.06.2022 | ||
| Former | The international publication has been made Status updated on 05.03.2021 | Most recent event Tooltip | 14.06.2024 | Application deemed to be withdrawn | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Numais Co., Ltd. 201, 202, 203, 2 FL., SK V1 center II, 31 Gwangnaru-ro 8-gil Seongdong-gu Seoul 04799 / KR | [2022/27] | Inventor(s) | 01 /
SUNG, Hak Joon 101-502, 22, Seolleung-ro 126-gil Gangnam-gu Seoul 06092 / KR | 02 /
YOON, Jeong Kee 504, 107, Gwanak-ro Gwanak-gu Seoul 08833 / KR | [2022/27] | Representative(s) | Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2022/27] | Miller, David James, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 20856044.1 | 28.08.2020 | [2022/27] | WO2020KR11581 | Priority number, date | KR20190107218 | 30.08.2019 Original published format: KR 20190107218 | [2022/27] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021040473 | Date: | 04.03.2021 | Language: | KO | [2021/09] | Type: | A1 Application with search report | No.: | EP4024048 | Date: | 06.07.2022 | Language: | EN | [2022/27] | Search report(s) | International search report - published on: | KR | 04.03.2021 | (Supplementary) European search report - dispatched on: | EP | 17.11.2023 | Classification | IPC: | G01N33/554, G01N33/68, A61K35/28, A61K38/17, A61P9/10, C07K7/08 | [2022/27] | CPC: |
G01N33/6893 (EP,KR,US);
G01N33/554 (KR,US);
C12N5/0607 (EP,US);
A61K35/28 (EP,KR,US);
A61K38/177 (KR,US);
A61P9/10 (EP,KR,US);
C07K7/08 (EP,KR,US);
C12N5/0663 (EP,US);
A61K38/00 (EP);
C07K2319/02 (KR);
C07K2319/03 (EP,KR);
C07K7/06 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/27] | Title | German: | VERFAHREN ZUR DIAGNOSE UND BEHANDLUNG VON ATHEROSKLEROSE DURCH VERWENDUNG EINER NANOVESIKEL-ZIELSTELLE ZUR VERÄNDERUNG DES BLUTFLUSSES | [2022/27] | English: | METHOD FOR DIAGNOSING AND TREATING ATHEROSCLEROSIS BY USING NANOVESICLE TARGETING SITE OF CHANGE IN BLOOD FLOW | [2022/27] | French: | MÉTHODE DE DIAGNOSTIC ET DE TRAITEMENT DE L'ATHÉROSCLÉROSE À L'AIDE D'UN SITE DE CIBLAGE DE NANOVÉSICULE DANS LE FLUX SANGUIN | [2022/27] | Entry into regional phase | 18.03.2022 | Translation filed | 18.03.2022 | National basic fee paid | 18.03.2022 | Search fee paid | 18.03.2022 | Designation fee(s) paid | 18.03.2022 | Examination fee paid | Examination procedure | 18.03.2022 | Amendment by applicant (claims and/or description) | 18.03.2022 | Examination requested [2022/27] | 01.03.2024 | Application deemed to be withdrawn, date of legal effect [2024/29] | 22.03.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/29] | Fees paid | Renewal fee | 25.08.2022 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.08.2023 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2018004143 (AMOREPACIFIC CORP [KR], et al) [A] 1-10; | [I] - HOFMEISTER LUCAS H. ET AL, "Phage-Display-Guided Nanocarrier Targeting to Atheroprone Vasculature", ACS NANO, US, vol. 9, no. 4, doi:10.1021/acsnano.5b01048, ISSN 1936-0851, (20150313), pages 4435 - 4446, URL: https://pubs.acs.org/doi/abs/10.1021/acsnano.5b01048, XP055787394 [I] 1-10 * abstract, table 1 * DOI: http://dx.doi.org/10.1021/acsnano.5b01048 | [A] - FUJITA YU ET AL, "Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases", JOURNAL OF CLINICAL MEDICINE, CH, vol. 7, no. 10, doi:10.3390/jcm7100355, ISSN 2077-0383, (20181001), pages 1 - 21, URL: https://www.mdpi.com/2077-0383/7/10/355, XP055787398 [A] 1-10 DOI: http://dx.doi.org/10.3390/jcm7100355 | [A] - CONSUELO MERINO-GONZÁLEZ ET AL, "Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application", FRONTIERS IN PHYSIOLOGY, CH, (20160209), vol. 7, doi:10.3389/fphys.2016.00024, ISSN 1664-042X, XP055398494 [A] 1-10 DOI: http://dx.doi.org/10.3389/fphys.2016.00024 | [A] - ARSALAN SHABBIR ET AL, "Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro", STEM CELLS AND DEVELOPMENT, US, (20150715), vol. 24, no. 14, doi:10.1089/scd.2014.0316, ISSN 1547-3287, pages 1635 - 1647, XP055583096 [A] 1-10 DOI: http://dx.doi.org/10.1089/scd.2014.0316 | International search | [A]KR20180003322 (AMOREPACIFIC CORP [KR], et al) [A] 1-8,11* See entire document. *; | [AY] - Hofmeister Lucas H., Lee Sue Hyun, Norlander Allison E., Montaniel Kim Ramil C., Chen Wei, Harrison David G., Sung Hak-Joon ACS Nano, "Phage-Display-Guided Nanocarrier Targeting to Atheroprone Vasculature", ACS Nano, (20150313), vol. 9, no. 4, doi:10.1021/acsnano.5b01048, pages 4435 - 4446, XP055787394 [A] 3,4,6 * See abstract; pages 4436-4438 and 4442-4444; and table 1. * [Y] 1,2,5,7,8,11 DOI: http://dx.doi.org/10.1021/acsnano.5b01048 | [Y] - Fujita Yu, Kadota Tsukasa, Araya Jun, Ochiya Takahiro, Kuwano Kazuyoshi, "Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases", Journal of Clinical Medicine, (20181014), vol. 7, no. 10, doi:10.3390/jcm7100355, pages 1 - 21, XP055787398 [Y] 1,2,5,7,8,11 * See abstract; and pages 3, 5, 6 and 14. * DOI: http://dx.doi.org/10.3390/jcm7100355 | [A] - Kelley William J., Safari Hanieh, Lopez-Cazares Genesis, Eniola-Adefeso Omolola, "Vascular‐targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases", Nanomedicine and Nanobiotechnology, United States, (20160519), vol. 8, no. 6, doi:10.1002/wnan.1414, ISSN 1939-5116, pages 909 - 926, XP055787402 [A] 1-8,11 * See entire document. * DOI: http://dx.doi.org/10.1002/wnan.1414 | [A] - Gupta Mukesh K., Lee Yunki, Boire Timothy C., Lee Jung-Bok, Kim Won Shik, Sung Hak-Joon, "Recent strategies to design vascular theranostic nanoparticles", Nanotheranostics, (20170406), vol. 1, no. 2, doi:10.7150/ntno.18531, ISSN 2206-7418, pages 166 - 177, XP055787408 [A] 1-8,11 * See entire document. * DOI: http://dx.doi.org/10.7150/ntno.18531 | by applicant | - SEI, Y. J. et al., Sci Rep, (20170000), vol. 7, page 10019 |